[ Price : $8.95]
In its latest batch of Warning Letters FDA cites Heritage Pharmaceuticals and Life Support Development.[ Price : $8.95]
FDAs New Jersey District Office warns Heritage Pharmaceuticals about violations of Postmarketing Adverse Drug Event Reporting requ...[ Price : $8.95]
PhRMA says a study on compliance with clinical trial reporting requirements published online by BMJ Open spreads misinformation an...[ Price : $8.95]
Federal Register Notice: FDA issues a priority review voucher to Alexion Pharmaceuticals for Strensiq, a therapy for infantile- an...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug...[ Price : $8.95]
Federal Register Proposed rule: FDA re-proposes to classify in vitro diagnostic devices for Bacillus species (spp.) detection into...[ Price : $8.95]
The American Medical Association votes to support a ban on pharmaceutical direct-to-consumer (DTC) advertising.[ Price : $8.95]
FDA posts a final guidance on Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants.